Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised Egetis Therapeutics in connection with a combined financing comprising an equity private placement and debt financing
Mandate

Vinge has advised Egetis Therapeutics in connection with a combined financing comprising an equity private placement and debt financing

October 13, 2023 Banking and Finance Capital Markets and Public M&A

Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), an innovative and integrated pharmaceutical company focusing on projects in late-stage development for commercialization for treatments of serious diseases with significant unmet medical needs in the orphan drug segment, listed on Nasdaq Stockholm, in connection with a combined financing comprising a SEK 172 million equity private placement and a SEK 290 million debt financing.

Vinge’s team consisted of Dain Hård Nevonen, Amanda Knutsson, Lorin Arabi and Isabell Bitar (Capital Markets and Public M&A) and of Albert Wållgren, Arvid Weimers and Ida Redander (Banking and finance).

Related

Vinge advises on the sale of Compab to Tången

 Vinge has advised the owners of Compab Energiteknik in connection with the sale of 80 per cent of the shares to Tången Industrikapital. Compab, which has a turnover of approximately SEK 100 million, sells, installs and services, amongst other things, steam and hot-water boilers as well as burners for the industrial sector.
October 26, 2026

Vinge advises Capio on the acquisition of Rehabhotellet Sthlm AB

 Rehabhotellet i Sthlm AB provides advanced home healthcare and specialized inpatient palliative care within the Stockholm Region.
October 26, 2026

Vinge advises Ikano Bank on acquisition of loan portfolio from Entercard

 Vinge has advised Ikano Bank AB (publ) on the acquisition of a portfolio of performing consumer loans from Entercard Group AB. As at 30 September 2026, the contractual amount of the loans totalled approximately SEK 7 billion.
October 26, 2026